Back to BARCLAYS PLC BARCLAYS PLC

TOVXTOVX
5 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in THERIVA BIOLOGICS INC

Yes. Barclays holds 3 shares of TOVX (Theriva Biologics), worth $1, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$1

Current Shares

3

Total Value Change

-$682

Total Shares Change

-492

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
3
-
$10.0%$0.25
17
2026-Q1
Exited
0
-100.0%
$00.0%$0.19
0
2025-Q4
New
32,569
-
$6,8530.0%$0.20
25
2024-Q4
Exited
0
-100.0%
$00.0%$1.50
0
2024-Q3
New
495
-
$6830.0%$1.49
17

Other major holders of TOVX: VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC, VANGUARD FIDUCIARY TRUST CO

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used